发明名称 Pharmaceutically Active Compounds
摘要 Compounds of the formula (I): wherein R1, R2, R4 and R13 are as defined or a pharmaceutically or veterinarily acceptable salt or polymorph thereof, or a pharmaceutically or veterinarily acceptable solvate or pro-drug thereof: are potent and selective inhibitors of type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP PDE5) and have utility in the treatment of, inter alia, male erectile dysfunction (MED) and female sexual dysfunction (FSD).
申请公布号 US2010035891(A1) 申请公布日期 2010.02.11
申请号 US20090469311 申请日期 2009.05.20
申请人 PFIZER INC 发明人 BUNNAGE MARK EDWARD;DEVRIES KEITH MICHAEL;HARRIS LAURENCE JAMES;LEVETT PHILIP CHARLES;MATHIAS JOHN PAUL;NEGRI JOANNA TERESA;STREET STEPHEN DEREK ALBERT;WOOD ALBERT SHAW
分类号 A61K31/496;C07D231/16;A61K;A61K31/519;A61P;A61P1/00;A61P3/10;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P9/14;A61P11/00;A61P11/02;A61P11/06;A61P13/00;A61P13/02;A61P13/08;A61P13/10;A61P15/06;A61P15/08;A61P15/10;A61P17/00;A61P17/06;A61P17/14;A61P25/00;A61P25/02;A61P25/28;A61P27/02;A61P27/06;A61P35/00;A61P35/04;A61P37/08;A61P43/00;C07B61/00;C07D;C07D213/80;C07D213/803;C07D231/38;C07D401/04;C07D401/12;C07D401/14;C07D403/04;C07D487/04;C07F7/18 主分类号 A61K31/496
代理机构 代理人
主权项
地址